BRPI0407243A - Método e composição que usam astaxantina - Google Patents
Método e composição que usam astaxantinaInfo
- Publication number
- BRPI0407243A BRPI0407243A BR0407243-0A BRPI0407243A BRPI0407243A BR PI0407243 A BRPI0407243 A BR PI0407243A BR PI0407243 A BRPI0407243 A BR PI0407243A BR PI0407243 A BRPI0407243 A BR PI0407243A
- Authority
- BR
- Brazil
- Prior art keywords
- astaxanthin
- pet
- methods
- compositions
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 7
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title abstract 4
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 title abstract 4
- 229940022405 astaxanthin Drugs 0.000 title abstract 4
- 235000013793 astaxanthin Nutrition 0.000 title abstract 4
- 239000001168 astaxanthin Substances 0.000 title abstract 4
- 241000824799 Canis lupus dingo Species 0.000 abstract 1
- 241000282326 Felis catus Species 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- MQZIGYBFDRPAKN-UWFIBFSHSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-UWFIBFSHSA-N 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/179—Colouring agents, e.g. pigmenting or dyeing agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Toxicology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Fodder In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Feed For Specific Animals (AREA)
Abstract
"MéTODOS E COMPOSIçõES QUE USAM ASTAXANTINA". A presente invenção refere-se a métodos e as composições que são úteis para um animal de estimação, em que os métodos e composições utilizam astaxantina. As composições compreendem astaxantina, em que a composição é adaptada para o uso por um animal de estimação. Os métodos são selecionados do grupo consistindo em atenuação de inflamação, acentuação de imunidade, acentuação de longevidade e combinações desses itens, compreendendo a administração, a um animal de estimação, de uma composição compreendendo uma quantidade eficaz de astaxantina. O animal de estimação é, na modalidade preferencial, um cão ou gato doméstico.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44507703P | 2003-02-05 | 2003-02-05 | |
| PCT/US2004/003220 WO2004071211A1 (en) | 2003-02-05 | 2004-02-05 | Methods and compositions utilizing astaxanthin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0407243A true BRPI0407243A (pt) | 2006-01-31 |
Family
ID=32869312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0407243-0A BRPI0407243A (pt) | 2003-02-05 | 2004-02-05 | Método e composição que usam astaxantina |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20040151761A1 (pt) |
| EP (1) | EP1589827B1 (pt) |
| JP (1) | JP4263192B2 (pt) |
| CN (1) | CN1744826A (pt) |
| AR (1) | AR043113A1 (pt) |
| AU (1) | AU2004211904A1 (pt) |
| BR (1) | BRPI0407243A (pt) |
| CA (1) | CA2514750C (pt) |
| ES (1) | ES2636493T3 (pt) |
| MX (1) | MXPA05008296A (pt) |
| RU (1) | RU2005124966A (pt) |
| WO (1) | WO2004071211A1 (pt) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060217445A1 (en) * | 2003-07-25 | 2006-09-28 | Chew Boon P | Natural astaxanthin extract reduces dna oxidation |
| JP4903569B2 (ja) * | 2003-09-12 | 2012-03-28 | アクセス ビジネス グループ インターナショナル エルエルシー | サイトカインモジュレータ及び関係する使用法 |
| US7758903B2 (en) | 2003-09-12 | 2010-07-20 | Access Business Group International Llc | Cytokine modulators and related methods of use |
| US7758902B2 (en) | 2003-09-12 | 2010-07-20 | Access Business Group International Llc | Cytokine modulators and related methods of use |
| US8921422B2 (en) * | 2003-10-01 | 2014-12-30 | The Iams Company | Methods and kits for enhancing ability to learn in a puppy or kitten |
| WO2005058064A1 (ja) | 2003-12-19 | 2005-06-30 | Menicon Co., Ltd. | アスタキサンチン配合ペット用食物 |
| WO2005089567A1 (en) | 2004-03-17 | 2005-09-29 | Nestec S.A. | Compositions and methods for reducing or preventing obesity |
| WO2005099479A1 (en) * | 2004-04-16 | 2005-10-27 | Nestec S.A. | Methods and compositions for reducing oxidative stress in an animlal |
| US20050266051A1 (en) * | 2004-05-27 | 2005-12-01 | The Procter & Gamble Company | Pet food compositions and methods |
| AU2006253007B2 (en) * | 2005-05-31 | 2012-12-20 | Alimentary Health Ltd | Feline probiotic Bifidobacteria |
| CA2609617C (en) * | 2005-05-31 | 2014-07-08 | The Iams Company | Feline probiotic lactobacilli |
| BRPI0618222A2 (pt) | 2005-11-02 | 2011-08-23 | Nestec Sa | composições de isoflavona para reduzir o acúmulo de gordura corporal em animais machos, e métodos para seu uso |
| DE202006020886U1 (de) | 2005-11-28 | 2010-09-23 | U.S. Nutraceuticals Llc Dba Valensa International | Algen- und Algenextrakt-Nahrungsergänzungszusammensetzung |
| US7682619B2 (en) * | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
| JP2014501536A (ja) * | 2011-01-14 | 2014-01-23 | ザ・アイムス・カンパニー | カロチノイドに関連する組成物及び方法 |
| CN107846938A (zh) * | 2015-05-20 | 2018-03-27 | 印第安纳大豆联盟有限公司 | 通过鲑科鱼提高大豆蛋白利用率的方法 |
| US20200205442A1 (en) * | 2018-12-28 | 2020-07-02 | Unicharm Corporation | Comprehensive nutrition pet food |
| CN112515049A (zh) * | 2020-11-09 | 2021-03-19 | 南京未来宠物产业研究院有限公司 | 一种虾青素在制备功能性宠物食品中的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5356810A (en) * | 1987-04-15 | 1994-10-18 | Gist-Brocades N.V. | Astaxanthin-producing yeast cells, methods for their preparation and their use |
| SE9401738D0 (sv) * | 1994-05-19 | 1994-05-19 | Ewos Ab | Bioactive feed |
| SE503336C2 (sv) * | 1994-09-19 | 1996-05-28 | Asta Carotene Ab | Medel och sätt för att öka produktionen av/hos fjäderfän |
| SE506191C2 (sv) * | 1996-03-27 | 1997-11-17 | Astacarotene Ab | Medel och sätt för att öka produktionen av/hos däggdjur |
| US5937790A (en) * | 1996-12-18 | 1999-08-17 | Showa Denko Kabushiki Kaisha | Anti-stress agent for animals and a method of reducing stress in animals |
| SE522246C2 (sv) * | 1997-02-27 | 2004-01-27 | Astacarotene Ab | Oralt preparat för profylaktisk och terapeutisk behandling av Helicobacter Sp. infektion |
| US6133323A (en) * | 1997-04-09 | 2000-10-17 | The Iams Company | Process for enhancing immune response in animals using β-carotene as a dietary supplement |
| ES2248087T5 (es) * | 1999-05-27 | 2012-02-21 | The Iams Company | Procedimiento para fabricar un producto para aumentar la respuesta inmune de animales de compañía usando una combinación de antioxidantes. |
| WO2002079395A2 (en) * | 2001-01-26 | 2002-10-10 | Cargill, Incorporated | Carotenoid biosynthesis |
| WO2002098373A1 (en) * | 2001-06-01 | 2002-12-12 | Animal Health Ventures, Inc. | Methods and products for bad breath |
| CN100420388C (zh) * | 2001-08-22 | 2008-09-24 | 搜莱有限公司 | 脂肪和可溶性糖含量降低的大豆粉、以及制造和使用这种大豆粉的方法 |
| EP1461058A2 (en) * | 2001-12-04 | 2004-09-29 | Pedro E. Levy | Supplements containing annatto extracts and carotenoids and methods for using the same |
-
2004
- 2004-01-23 US US10/764,215 patent/US20040151761A1/en not_active Abandoned
- 2004-02-05 WO PCT/US2004/003220 patent/WO2004071211A1/en not_active Ceased
- 2004-02-05 ES ES04708561.8T patent/ES2636493T3/es not_active Expired - Lifetime
- 2004-02-05 JP JP2005518375A patent/JP4263192B2/ja not_active Expired - Lifetime
- 2004-02-05 CA CA002514750A patent/CA2514750C/en not_active Expired - Lifetime
- 2004-02-05 MX MXPA05008296A patent/MXPA05008296A/es active IP Right Grant
- 2004-02-05 BR BR0407243-0A patent/BRPI0407243A/pt not_active Application Discontinuation
- 2004-02-05 AU AU2004211904A patent/AU2004211904A1/en not_active Abandoned
- 2004-02-05 EP EP04708561.8A patent/EP1589827B1/en not_active Expired - Lifetime
- 2004-02-05 CN CNA200480003244XA patent/CN1744826A/zh active Pending
- 2004-02-05 RU RU2005124966/13A patent/RU2005124966A/ru not_active Application Discontinuation
- 2004-02-06 AR ARP040100376A patent/AR043113A1/es not_active Application Discontinuation
-
2016
- 2016-09-28 US US15/279,265 patent/US20170014356A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2636493T3 (es) | 2017-10-05 |
| RU2005124966A (ru) | 2006-02-10 |
| AU2004211904A1 (en) | 2004-08-26 |
| CA2514750C (en) | 2009-07-21 |
| CN1744826A (zh) | 2006-03-08 |
| CA2514750A1 (en) | 2004-08-26 |
| WO2004071211A1 (en) | 2004-08-26 |
| JP4263192B2 (ja) | 2009-05-13 |
| MXPA05008296A (es) | 2005-09-20 |
| EP1589827A1 (en) | 2005-11-02 |
| AR043113A1 (es) | 2005-07-20 |
| US20170014356A1 (en) | 2017-01-19 |
| US20040151761A1 (en) | 2004-08-05 |
| EP1589827B1 (en) | 2017-05-03 |
| JP2006515178A (ja) | 2006-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0407243A (pt) | Método e composição que usam astaxantina | |
| DE602004018680D1 (de) | Verfahren zur verringerung des exkrementgeruchs von heimtieren | |
| BRPI0517423A (pt) | composto, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psiquiátricos associados com disfunção do glutamato em um animal, e, uso em um composto | |
| BRPI0911031B8 (pt) | compostos de piperidina ligada do tipo quinoxalina substituídos e os usos destes | |
| BRPI0407730A (pt) | composições de limpeza de superfìcies rìgidas | |
| MEP48108A (en) | 4-tetrazolyl-4phenylpiperidine derivatives for treating pain | |
| BRPI0800372A2 (pt) | complexos (quelatos) metÁlicos heteromoleculares | |
| BRPI0906478B8 (pt) | anticorpo anti-nr10, seu uso e composição farmacêutica que o compreende | |
| MX379353B (es) | Compuesto de piperidina tipo quinoxalina sustituida y uso de los mismos. | |
| BRPI0408236A (pt) | método para radiofluoração, composto, composição radiofarmacêutica, uso de um composto, e, métodos para gerar uma imagem de um corpo humano ou animal e para monitorar o efeito de tratamento de um corpo humano ou animal com um medicamento para combater uma condição associada com cáncer | |
| BRPI0713349A2 (pt) | Inibidores de proteína tirosina fosfatase humana e métodos de utilização | |
| BR112012015960A2 (pt) | Composições incluindo piruvato para animais de companhia e métodos de uso destas. | |
| BRPI0415960A (pt) | composto ou um sal do mesmo, pró-droga de um composto, agente farmacêutico, inibidor de peptidase, composto ou um sal do mesmo, pró-droga de um composto, agente farmacêutico, inibidor de peptidase, uso de um composto,e, método para produzir um composto | |
| BRPI0713357A2 (pt) | Inibidores de proteína tirosina fosfatase humana e método de utilização. | |
| MX2008013619A (es) | Aumento del titulo para vacunacion en animales. | |
| EA200702093A1 (ru) | Антитела-миметики glp-1 человека, композиции, способы и их применение | |
| EA200970131A1 (ru) | Миметические антитела для glp-1 человека, композиции, способы и применения | |
| BRPI0511477A (pt) | compostos e composições como moduladores de ppar | |
| BR112013018839A2 (pt) | métodos e composições para o tratamento, a redução ou a prevenção de deterioração do sistema visual dos animais | |
| BRPI0417166A (pt) | composições compreendendo fibra fermentável, adaptadas para uso por um animal de estimação, e kits e métodos para uso das mesmas | |
| BRPI0519135A2 (pt) | macrolÍdeos | |
| BR0312768A (pt) | Compostos de 5-ariltetrazol, composições do mesmo e usos dos mesmos | |
| BRPI0406596A (pt) | Métodos para tratar a dor articular e melhorar o sono utilizando um agonista/antagonista de estrogênio | |
| BRPI0506699A (pt) | método para lavar aves domésticas durante o processamento com composições de ácido peroxicarboxìlicos de cadeias médias | |
| PL1965809T3 (pl) | Kompozycje do poprawiania zdrowia jelit i użytkowości zwierząt zawierające beta-glukany i alfa-fukany |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
| B07A | Technical examination (opinion): publication of technical examination (opinion) | ||
| B07A | Technical examination (opinion): publication of technical examination (opinion) | ||
| B09B | Decision: refusal |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM OS ARTIGOS 8O E 11 DA LPI |
|
| B09B | Decision: refusal |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |
|
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 31/122 (2006.01), A23K 20/179 (2016.01), A23K |